ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Pharming Group NV

Pharming Group NV (PHARM)

0,8765
-0,0135
( -1,52% )
Mis à jour : 12:42:00

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
0,8765
Prix Achat
0,8755
Prix Vente
0,8775
Volume échangé
1 563 042
0,8745 Fourchette du Jour 0,89
0,6475 Plage de 52 semaines 1,22
Cap du marché
Clôture Veille
0,89
Ouverture
0,89
Dernière Transaction
371
@
0.8765
Dernière heure de transaction
12:39:14
Volume financier
-
VWAP
-
Volume moyen (3 m)
5 928 751
Actions en circulation
646 123 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-53,99
Bénéfice par action (BPA)
-0,02
Chiffre d'affairess
245,32M
Bénéfice net
-10,55M

À propos de Pharming Group NV

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Diversified
Site Web
Siège social
Leiden, South Holland, Nld
Fondé
1988
Pharming Group NV est coté dans le secteur Pharmaceutical Preparations de la Euronext avec le ticker PHARM. Le dernier cours de clôture d'Pharming Group NV était de 0,89 €. Au cours de la dernière année, les actions de Pharming Group NV ont été négociées dans une fourchette de prix de 0,6475 € à 1,22 €.

Pharming Group NV compte actuellement 646 123 000 actions en circulation. La capitalisation boursière d'Pharming Group NV est de 575,05 € million. Pharming Group NV a un ratio cours/bénéfice (ratio PE) de -53.99.

PHARM Dernières nouvelles

Pharming Group to convene Extraordinary General Meeting of Shareholders

Pharming Group to convene Extraordinary General Meeting of Shareholders Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam:...

Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer

Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or...

Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer

Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Board of Directors has nominated...

Pharming announces public cash offer to the shareholders of Abliva AB

Pharming announces public cash offer to the shareholders of Abliva AB Proposed acquisition strengthens Pharming’s late-stage pipeline with a potential first-in-disease asset Abliva’s lead product...

Pharming announces public cash offer to the shareholders of Abliva AB

Proposed acquisition strengthens Pharming’s late-stage pipeline with a potential first-in-disease asset Abliva’s lead product KL1333 is currently in a pivotal clinical trial, with a positive...

Pharming announces positive topline data in pediatric clinical trial of leniolisib

Multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency Data consistent with the improvements seen in the...

Pharming announces positive topline data in pediatric clinical trial of leniolisib

Pharming announces positive topline data in pediatric clinical trial of leniolisib Multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare...

Pharming Group to participate in November investor conference

Leiden, the Netherlands, November 5, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor...

Pharming Group reports third quarter 2024 financial results and provides business update

Pharming Group reports third quarter 2024 financial results and provides business update Third quarter 2024 total revenues increased by 12% to US$74.8 million, compared to the third quarter 2023...

Pharming Group reports third quarter 2024 financial results and provides business update

Third quarter 2024 total revenues increased by 12% to US$74.8 million, compared to the third quarter 2023, driven by continued strong RUCONEST® and Joenja® revenue growthRUCONEST® third quarter...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.041-4.468664850140.91750.92550.874530726940.90775928DE
4-0.0175-1.957494407160.8940.96850.874558102340.92576108DE
120.0718.814400993170.80550.96850.68359287510.83793466DE
260.108514.12760416670.7680.96850.647552393220.79180561DE
52-0.2335-21.0360360361.111.220.647554094200.87609268DE
1560.087511.08998732570.7891.4190.647560368961.01801111DE
260-0.5735-39.55172413791.451.49950.647567660991.05129677DE

PHARM - Frequently Asked Questions (FAQ)

What is the current Pharming Group NV share price?
The current share price of Pharming Group NV is 0,8765 €
How many Pharming Group NV shares are in issue?
Pharming Group NV has 646 123 000 shares in issue
What is the market cap of Pharming Group NV?
The market capitalisation of Pharming Group NV is EUR 575,05M
What is the 1 year trading range for Pharming Group NV share price?
Pharming Group NV has traded in the range of 0,6475 € to 1,22 € during the past year
What is the PE ratio of Pharming Group NV?
The price to earnings ratio of Pharming Group NV is -53,99
What is the cash to sales ratio of Pharming Group NV?
The cash to sales ratio of Pharming Group NV is 2,32
What is the reporting currency for Pharming Group NV?
Pharming Group NV reports financial results in USD
What is the latest annual turnover for Pharming Group NV?
The latest annual turnover of Pharming Group NV is USD 245,32M
What is the latest annual profit for Pharming Group NV?
The latest annual profit of Pharming Group NV is USD -10,55M
What is the registered address of Pharming Group NV?
The registered address for Pharming Group NV is VONDELLAAN 47, LEIDEN, SOUTH HOLLAND, 2332 AA
What is the Pharming Group NV website address?
The website address for Pharming Group NV is www.pharming.com
Which industry sector does Pharming Group NV operate in?
Pharming Group NV operates in the PHARMACEUTICAL DIVERSIFIED sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ALMASMastrad
0,0224 €
(128,57%)
20,57M
MLAATAzorean Tech
0,16 €
(60,00%)
1,05k
CDUConduril Engenharia SA
24,60 €
(30,16%)
150
ALNMRNamR SA
0,17 €
(26,39%)
39,97k
GNROGeNeuro SA
0,162 €
(20,00%)
793,64k
MLWEYWeya
0,02 €
(-23,08%)
1,5k
POXELPoxel
0,317 €
(-18,82%)
2,28M
ALBIOBiosynex
1,66 €
(-17,82%)
50,23k
ALNEVNeovacs
0,5112 €
(-17,55%)
10,52k
ALVETEGEIRO Pharma
0,0912 €
(-16,33%)
4,95k
ATOAtos SE
0,0022 €
(0,00%)
210,55M
BCPBanco Comercial Portugues SA
0,5136 €
(0,23%)
30,58M
ALMASMastrad
0,0224 €
(128,57%)
20,57M
ALCYBCybergun
0,0001 €
(0,00%)
15,68M
ALVERVergnet
0,0015 €
(7,14%)
11,57M

Dernières Valeurs Consultées

Delayed Upgrade Clock